Last checked at 11 Jan 2023 07:00
11 January 2023
ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")
AIM: ACRL
Notice of Half Year Results, Outcomes of Strategic Review, and Online Presentations
Accrol, the UK's leading independent tissue converter, announces that it will release its Half Year Results for the six months ended 31 October 2022, alongside the outcomes of the Strategic Review, on Tuesday, 24 January 2023.
An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.
As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Friday, 27 January at 12.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H123_results_webinar.
For further information, please contact:
Accrol Group Holdings plc Dan Wright, Executive Chairman Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer
| Via Belvedere Communications |
Zeus (Nominated Adviser & Broker) Dan Bate / Jordan Warburton (Investment Banking) Dominic King (Corporate Broking)
|
Tel: +44 (0) 161 831 1512 Tel: +44 (0) 203 829 5000 |
Liberum Capital Limited (Joint Broker) Clayton Bush / Edward Thomas
|
Tel: +44 (0) 20 3100 2222 |
Belvedere Communications Limited Cat Valentine Keeley Clarke |
Tel: +44 (0) 7715 769 078 Tel: +44 (0) 7967 816 525 accrolpr@belvederepr.com |
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which now supplies 21.5% (volume) of the UK tissue market valued at £2.1bn at retail sales value.
The Group has produced a short video to showcase its operations and investment in the extensive automation of the business. Click here: Accrol Today.
For more information, please visit www.accrol.co.uk